27331407|t|Structural Insights into 5-HT1A / D4 Selectivity of WAY-100635 Analogues: Molecular Modeling, Synthesis, and in Vitro Binding
27331407|a|The resurgence of interest in 5-HT1A receptors as a therapeutic target requires the existence of highly selective 5-HT1A ligands. To date, WAY-100635 has been the prototypical antagonist of these receptors. However, this compound also has significant affinity for and activity at D4 dopamine receptors. In this context, this work was aimed at better understanding the 5-HT1A / D4 selectivity of WAY-100635 and analogues from a structural point of view. In silico investigations revealed two key interactions for the 5-HT1A / D4 selectivity of WAY-100635 and analogues. First, a hydrogen bond only found with the Ser 7.36 of D4 receptor appeared to be the key for a higher D4 affinity for newly synthesized aza analogues. The role of Ser 7.36 was confirmed as the affinity of aza analogues for the mutant D4 receptor S7.36A was reduced. Then, the formation of another hydrogen bond with the conserved Ser 5.42 residue appeared to be also critical for D4 binding.
27331407	0	10	Structural	T082	C0678594
27331407	11	19	Insights	T041	C0233820
27331407	25	31	5-HT1A	T116,T192	C0379900
27331407	34	36	D4	T116,T192	C0114835
27331407	37	48	Selectivity	T070	C1510827
27331407	52	62	WAY-100635	T109,T121	C0290799
27331407	63	72	Analogues	T104	C0243071
27331407	74	92	Molecular Modeling	T062,T170	C0600115
27331407	94	103	Synthesis	T052	C1883254
27331407	109	117	in Vitro	T080	C1533691
27331407	118	125	Binding	T044	C1167622
27331407	156	172	5-HT1A receptors	T116,T192	C0379900
27331407	178	189	therapeutic	T169	C0302350
27331407	190	196	target	T169	C1521840
27331407	230	239	selective	T080	C0205556
27331407	240	246	5-HT1A	T116,T192	C0379900
27331407	247	254	ligands	T103	C0023688
27331407	265	275	WAY-100635	T109,T121	C0290799
27331407	289	312	prototypical antagonist	T120	C0243076
27331407	322	331	receptors	T116,T192	C0597357
27331407	347	355	compound	T080	C0205198
27331407	377	385	affinity	UnknownType	C0683185
27331407	406	427	D4 dopamine receptors	T116,T192	C0114835
27331407	494	500	5-HT1A	T116,T192	C0379900
27331407	503	505	D4	T116,T192	C0114835
27331407	506	517	selectivity	T070	C1510827
27331407	521	531	WAY-100635	T109,T121	C0290799
27331407	536	545	analogues	T104	C0243071
27331407	553	563	structural	T082	C0678594
27331407	579	588	In silico	T066	C3489666
27331407	589	603	investigations	T169	C1292732
27331407	621	633	interactions	T169	C1704675
27331407	642	648	5-HT1A	T116,T192	C0379900
27331407	651	653	D4	T116,T192	C0114835
27331407	654	665	selectivity	T070	C1510827
27331407	669	679	WAY-100635	T109,T121	C0290799
27331407	684	693	analogues	T104	C0243071
27331407	704	717	hydrogen bond	T070	C0020276
27331407	738	746	Ser 7.36	T116,T121,T123	C0036720
27331407	750	761	D4 receptor	T116,T192	C0114835
27331407	798	800	D4	T116,T192	C0114835
27331407	801	809	affinity	UnknownType	C0683185
27331407	820	831	synthesized	T052	C1883254
27331407	832	835	aza	T109	C0004471
27331407	836	845	analogues	T104	C0243071
27331407	859	867	Ser 7.36	T116,T121,T123	C0036720
27331407	889	897	affinity	UnknownType	C0683185
27331407	901	904	aza	T109	C0004471
27331407	905	914	analogues	T104	C0243071
27331407	923	929	mutant	T049	C0596988
27331407	930	948	D4 receptor S7.36A	T116,T192	C0114835
27331407	993	1006	hydrogen bond	T070	C0020276
27331407	1026	1042	Ser 5.42 residue	T116,T121,T123	C0036720
27331407	1076	1078	D4	T116,T192	C0114835
27331407	1079	1086	binding	T044	C1167622